Molly Harper - 29 Jun 2021 Form 3 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Director
Signature
/s/ Molly Harper
Issuer symbol
CPRX
Transactions as of
29 Jun 2021
Net transactions value
$0
Form type
3
Filing time
08 Jul 2021, 16:28:23 UTC
Next filing
30 Dec 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CPRX Options to purchase Common Stock 29 Jun 2021 Common Stock 60,000 $5.78 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options will vest in three equal tranches on June 29, 2022, 2023 and 2024.